Liminal Pathways PLLC

Liminal Pathways PLLCLiminal Pathways PLLCLiminal Pathways PLLC
Home
About Liminal Pathways
FAQ
The Science of Ketamine

Liminal Pathways PLLC

Liminal Pathways PLLCLiminal Pathways PLLCLiminal Pathways PLLC
Home
About Liminal Pathways
FAQ
The Science of Ketamine
More
  • Home
  • About Liminal Pathways
  • FAQ
  • The Science of Ketamine
  • Home
  • About Liminal Pathways
  • FAQ
  • The Science of Ketamine

🧬 The Science Behind Ketamine for Mental Health

Rewiring the brain. Restoring the self.

Ketamine is a powerful therapeutic tool that works differently from traditional antidepressants. At low, controlled doses, ketamine supports neuroplasticity—helping the brain form new connections while easing symptoms of depression, anxiety, PTSD, and more. It can reduce patterns of rumination, support emotional processing, and open a window for deep transformation.

Unlike medications that may take weeks to work, ketamine’s effects can be felt within hours or days—and when paired with therapeutic support, its benefits are often amplified and sustained.

At Liminal Pathways, we integrate this powerful medicine into a ceremonial, trauma-informed model that honors both the science of healing and the soul’s capacity for renewal.

Find out more

Clinical Research & Resources

Here are a few trusted sources to explore the science behind ketamine

"Ketamine Offers Lifeline for People with Severe Depression"
Yale Medicine
https://www.yalemedicine.org/news/ketamine-depression


"Ketamine-assisted psychotherapy for trauma-exposed patients in an outpatient setting: A clinical chart review study"
https://akjournals.com/view/journals/2054/5/2/article-p94.xml

"Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression"
The American Journal of Psychiatry
https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2019.19070720

"Ketamine for Major Depression: New Tool, New Questions"
Harvard Health Publishing – Harvard Medical School
https://www.health.harvard.edu/blog/ketamine-for-major-depression-new-tool-new-questions-2019052216673

"Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study"
https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2022.948115/full

Copyright © 2025 Liminal Pathways - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept